Clinical Trial

OLANI PK/Safety Study in Healthy Volunteers

Study Description

OLANI PK/Safety Study in Healthy Volunteers

This study will examine the pharmacokinetic profile and safety of the O'Neil Long Acting Naltrexone Implant (OLANI) overtime in healthy volunteers. All participants will be treated in an open label manner. No randomization will occur. It is hypothesized that the OLANI will provide sustained therapeutic doses of naltrexone (NTX) for periods up to 6 months via a single subcutaneous application of 2 OLANIs.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - naltrexone implant

1.8 g implant containing 60% naltrexone

Additional Information

Official Study Title

A Pilot Pharmacokinetic (PK) Trial of the O'Neil Long Acting Naltrexone Implant

Clinical Trial ID

NCT03810495

ParticipAid ID

e73YGe